Cardiac assist devices sales will grow through 2036, led by ventricular assist devices at 68.0% of the product type segment in 2026, driven by clinical adoption and regulatory compliance requirements. The market was valued at USD 1.40 billion in 2025 and is expected to be worth USD 2.60 billion by 2036.